DS Pharma Animal Health
DS Pharma Animal Health is a Japanese veterinary pharmaceutical company that develops, manufactures, and distributes pharmaceuticals, nutritional supplements, and cell-based therapeutics for companion animals (dogs and cats) and livestock, selling primarily to veterinary clinics and livestock operations domestically.
- Company typePrivate
- Founded2010
- HeadquartersOsaka, Japan
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
DS Pharma Animal Health firmographics
Firmographics- Name
- DS Pharma Animal Health
- Legal name
- 物産アニマルヘルス株式会社
- Website
- https://animal.ds-pharma.co.jp
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- DS Pharma Animal Health is a Japanese veterinary pharmaceutical company that develops, manufactures, and distributes pharmaceuticals, nutritional supplements, and cell-based therapeutics for companion animals (dogs and cats) and livestock, selling primarily to veterinary clinics and livestock operations domestically.
- Ownership category
- akta.pro rank
DS Pharma Animal Health industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)
- akta.pro secondary industries
- Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM), Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Antimicrobials & Anti-infectives (HLAMAEAE), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK), Pet Pharmaceuticals & Veterinary Supply Distribution (CRAOAKAD)
Keywords
Where DS Pharma Animal Health is headquartered
LocationHeadquarters
- HQ city
- Osaka
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
DS Pharma Animal Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Veterinary Pharmaceuticals: Sale of pharmaceutical products including antibiotics (e.g., Lincomycin water-soluble powder), eye drops, and specialty medications for small animals and livestock through direct sales to veterinary clinics and livestock operations
- Nutritional Supplements: Sale of nutritional supplements for companion animals including hepatic support products, calming supplements, and urinary health products
- Cell Therapy Products: Cell-based pharmaceutical preparations for veterinary use, representing novel therapeutic approach
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
DS Pharma Animal Health product offering
Product offeringCore offering
DS Pharma Animal Health researches, manufactures, and sells veterinary pharmaceutical products for companion animals (dogs and cats) and livestock, including antibiotics, nutritional supplements, pheromone products, emetic ophthalmic solutions, and cell-based therapeutic preparations. Its cell-based pharmaceutical offering is positioned as Japan's first domestically developed cell-based veterinary therapeutic. Products are sold primarily through dedicated professional portals (Vet-i for veterinarians, smp-ls for livestock) and a sales force targeting veterinary clinics and livestock operations.
Differentiator
Problem solved
Functional benefit
Brands
- Vet-i (ヴェットアイ): Platform providing product information for small animal medical professionals specializing in dogs and cats.
- Calm Uroferl (カームウロフェル™)
- Feliway Friends (フェリウェイ フレンズ)
- HepatoSirop (ヘパシロップ®)
- Clevol (クレボル®)
Products and services
- Calm Uroferl (カームウロフェル™) Nutritional supplement for cats that supports urinary tract and behavioral health, targeted at companion animal owners and dispensed through veterinary clinics.
- Feliway Friends (フェリウェイ フレンズ) Pheromone product designed to manage feline stress and behavioral issues in companion cats, distributed through veterinary channels.
- Hepato Syrup for Dogs and Cats (犬猫用ヘパシロップ®) Hepatic support nutritional supplement formulated for both dogs and cats, distributed through veterinary clinics for companion animal liver health.
- Clevol (クレボル®) Emetic ophthalmic solution for dogs, used to induce vomiting in canine patients under veterinary supervision.
- Cell Medicine (細胞医療) Cell-based pharmaceutical preparations being developed for veterinary use, positioned as Japan's first domestically approved cell-based veterinary therapeutic. Targeted at veterinary clinics for advanced animal medical treatments.
- Lincomycin Water-Soluble Powder (リンコシン水溶散) Lincomycin-based antibiotic water-soluble powder for veterinary use; the company assumed manufacturing and sales approval for this antibacterial product.
- Novus Feed Additives (ノーバス飼料添加物) Feed additive products from Novus International distributed by DS Pharma Animal Health in Japan, serving livestock and agricultural operations.
- Companion Animal Pharmaceutical Products Comprehensive portfolio of pharmaceutical products for companion animals (dogs and cats) including antibiotics, eye drops, and specialty medications, organized alphabetically (ア行 through ワ行) on the Vet-i professional portal and sold to veterinary clinics.
- Livestock Pharmaceutical and Health Products (畜産製品) Pharmaceutical and health products for livestock animals, distributed through the dedicated livestock portal (smp-ls.jp) and serving livestock farmers and agricultural operations.
Companies that use DS Pharma Animal Health
Customer profileSegments3 records
Ideal customer profiles3 records
DS Pharma Animal Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
DS Pharma Animal Health partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Novus InternationalcoreDS Pharma Animal Health has taken on the distribution rights for Novus International's feed additive products in Japan. This partnership expands the company's livestock product portfolio to include Novus's feed additive offerings, complementing existing pharmaceutical products for the livestock sector.
Scale indicators2 records
DS Pharma Animal Health competitors and assessment
Company assessmentBroad incumbents
- Virbac: Global veterinary pharmaceutical company focused on companion animal health products including specialty therapeutics, parasiticides, and dermatology. Comparable in product portfolio depth and competes in the Japanese specialty vet pharma segment.
- Elanco Animal Health: Global animal health company providing pharmaceuticals, vaccines, and parasiticides for both companion animals and livestock. Competes with DS Pharma Animal Health in the veterinary pharmaceuticals space across multiple species.
- Zoetis: The world's largest standalone animal health company, offering a broad portfolio of veterinary pharmaceuticals, vaccines, and diagnostics across companion animals and livestock. Directly comparable to DS Pharma Animal Health in product categories and customer base, but at vastly greater global scale.
- Phibro Animal Health: Animal health and nutrition company providing pharmaceuticals, vaccines, and feed additives primarily for livestock, with some companion animal exposure. Comparable through the livestock segment and feed additive distribution that overlaps with the Novus partnership.
- Dechra Pharmaceuticals: Specialty veterinary pharmaceutical company focused on companion animal endocrinology, dermatology, and specialty therapeutics. Comparable in specialty pharma positioning and premium product strategy.
- Vetoquinol: International veterinary pharmaceutical company with strong presence in companion animal therapeutics across Europe, Americas, and Asia-Pacific. Comparable in mid-sized veterinary pharma positioning and product breadth.
- Boehringer Ingelheim Animal Health: Major global animal health division of Boehringer Ingelheim, offering veterinary pharmaceuticals, vaccines, and therapeutics for companion animals and livestock. Comparable in product mix (especially livestock and small animal therapeutics) and competes in the Japanese market.
Emerging players
- IDEXX Laboratories: Veterinary diagnostics and software company with some pharmaceutical adjacencies; primarily serves the companion animal veterinary channel in Japan. Comparable in customer base (Japanese veterinary clinics) but operates in a different product category (diagnostics).
Direct peers
- Kyoritsu Seiyaku Corporation: Japanese veterinary pharmaceutical company producing pharmaceuticals, feed additives, and animal health products for companion animals and livestock. Direct competitor in the Japanese market with similar distribution channels and product categories.
- Nippon Zenyaku Kogyo (Zenoaq): Japanese veterinary pharmaceutical manufacturer specializing in companion animal and livestock pharmaceuticals, including biologics. Most direct domestic peer to DS Pharma Animal Health with similar product portfolio, customer segments, and Japanese regulatory expertise.
Market position
Customer concentration
DS Pharma Animal Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
DS Pharma Animal Health leadership team
Management profileNumber of profiles
DS Pharma Animal Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DS Pharma Animal Health M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DS Pharma Animal Health
What does DS Pharma Animal Health do?
DS Pharma Animal Health researches, manufactures, and sells veterinary pharmaceutical products for companion animals (dogs and cats) and livestock, including antibiotics, nutritional supplements, pheromone products, emetic ophthalmic solutions, and cell-based therapeutic preparations. Its cell-based pharmaceutical offering is positioned as Japan's first domestically developed cell-based veterinary therapeutic. Products are sold primarily through dedicated professional portals (Vet-i for veterinarians, smp-ls for livestock) and a sales force targeting veterinary clinics and livestock operations.
Is DS Pharma Animal Health a public or private company?
DS Pharma Animal Health is a private company. It is classified as unknown and is currently operating.
When was DS Pharma Animal Health founded?
DS Pharma Animal Health was founded in 2010. It employs 101 to 250 people.
Where is DS Pharma Animal Health based?
DS Pharma Animal Health is headquartered in Osaka, Japan, in the Asia region.
How does DS Pharma Animal Health make money?
Three revenue lines are on record. Veterinary Pharmaceuticals are the primary driver. The others are nutritional Supplements and cell Therapy Products.
Who are DS Pharma Animal Health's main competitors?
Broad incumbents on record are Virbac, Elanco Animal Health, Zoetis, Phibro Animal Health, Dechra Pharmaceuticals, Vetoquinol and Boehringer Ingelheim Animal Health. IDEXX Laboratories is listed as an emerging player. Direct peers are Kyoritsu Seiyaku Corporation and Nippon Zenyaku Kogyo (Zenoaq).
Does DS Pharma Animal Health have an API?
No public API is recorded for DS Pharma Animal Health.
What industry is DS Pharma Animal Health in?
DS Pharma Animal Health's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAIAA, Veterinary Pharmaceutical Wholesalers & Distributors, with a secondary code of HLAMAEAM, Generic & Private-Label Veterinary Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.